Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of Multiple Ascending Doses of CG400549 in Healthy Volunteers

Trial Profile

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of Multiple Ascending Doses of CG400549 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 May 2013

At a glance

  • Drugs CG 400549 (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant Staphylococcus aureus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 13 May 2013 New source identified and integrated: ClinicalTrials.gov record.
    • 11 May 2011 Status changed from planning to completed, according to information in a CrystalGenomics media release.
    • 10 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top